(A)

1. (1) As used in this section:

   1. (a) "Another adult authorized to consent to the minor's medical treatment" means an adult to whom a minor's parent or guardian has given written authorization to consent to the minor's medical treatment.
   2. (b) "Medical emergency" means a situation that in a prescriber's good faith medical judgment creates an immediate threat of serious risk to the life or physical health of a minor.
   3. (c) "Minor" means an individual under eighteen years of age who is not emancipated.
2. (2) For purposes of this section, an individual under eighteen years of age is emancipated only if the individual has married, entered the armed services of the United States, became employed and self-sustaining, or has otherwise become independent from the care and control of the individual's parent, guardian, or custodian.

(B) Except as provided in division (C) of this section, before issuing for a minor the first prescription in a single course of treatment for a particular compound that is a controlled substance containing an opioid, regardless of whether the dosage is modified during that course of treatment, a prescriber shall do all of the following:

1. (1) As part of the prescriber's examination of the minor, assess whether the minor has ever suffered, or is currently suffering, from mental health or substance abuse disorders and whether the minor has taken or is currently taking prescription drugs for treatment of those disorders;

2. (2) Discuss with the minor and the minor's parent, guardian, or another adult authorized to consent to the minor's medical treatment all of the following:

   1. (a) The risks of addiction and overdose associated with the compound;
   2. (b) The increased risk of addiction to controlled substances of individuals suffering from both mental and substance abuse disorders;
   3. (c) The dangers of taking controlled substances containing opioids with benzodiazepines, alcohol, or other central nervous system depressants;
   4. (d) Any other information in the patient counseling information section of the labeling for the compound required under 21 C.F.R. 201.57(c)(18).

3. (3) Obtain written consent for the prescription from the minor's parent, guardian, or, subject to division (E) of this section, another adult authorized to consent to the minor's medical treatment. The prescriber shall record the consent on a form, which shall be known as the "Start Talking!" consent form. The form shall be separate from any other document the prescriber uses to obtain informed consent for other treatment provided to the minor. The form shall contain all of the following:

   1. (a) The name and quantity of the compound being prescribed and the amount of the initial dose;
   2. (b) A statement indicating that a controlled substance is a drug or other substance that the United States drug enforcement administration has identified as having a potential for abuse;
   3. (c) A statement certifying that the prescriber discussed with the minor and the minor's parent, guardian, or another adult authorized to consent to the minor's medical treatment the matters described in division (B)(2) of this section;
   4. (d) The number of refills, if any, authorized by the prescription;
   5. (e) The signature of the minor's parent, guardian, or another adult authorized to consent to the minor's medical treatment and the date of signing.

(C)

1. (1) The requirements in division (B) of this section do not apply if the minor's treatment with a compound that is a controlled substance containing an opioid meets any of the following criteria:

   1. (a) The treatment is associated with or incident to a medical emergency.
   2. (b) The treatment is associated with or incident to surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.
   3. (c) In the prescriber's professional judgment, fulfilling the requirements of division (B) of this section with respect to the minor's treatment would be a detriment to the minor's health or safety.
   4. (d) Except as provided in division (D) of this section, the treatment is rendered in a hospital, ambulatory surgical facility, nursing home, pediatric respite care program, residential care facility, freestanding rehabilitation facility, or similar institutional facility.
2. (2) The requirements in division (B) of this section do not apply to a prescription for a compound that is a controlled substance containing an opioid that a prescriber issues to a minor at the time of discharge from a facility or other location described in division (C)(1)(d) of this section.